Amyloid Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Amyloid stocks.

Amyloid Stocks Recent News

Date Stock Title
Jul 1 LLY Lilly in deal with Radionetics Oncology on radiopharmaceuticals development
Jul 1 LLY Sanofi Nears Decision on $1.6B Upgrade For Frankfurt Insulin Plant
Jul 1 LLY Eli Lilly Soars To 52-Week High: Can The Momentum Continue?
Jul 1 GMAB AbbVie (ABBV) Gets CHMP Nod for Lymphoma Drug's Expanded Use
Jul 1 LLY Nvidia Among Biggest Stock Market Winners In 2024, But This Is No. 1
Jul 1 LLY Eli Lilly & Co (NYSE:LLY): Jim Cramer’s Best Weight Loss Stock Pick for 2024
Jul 1 LLY Want Decades of Passive Income? 2 Top Dividend Stocks to Buy Now and Hold Forever.
Jul 1 LLY Atossa Therapeutics updates protocol for breast cancer treatment trial
Jul 1 LLY 10 clinical trials to watch in the second half of 2024
Jul 1 LLY Alnylam, Lilly, AstraZeneca among best performing pharmas, biotechs in Q2
Jul 1 ALNY Alnylam, Lilly, AstraZeneca among best performing pharmas, biotechs in Q2
Jun 30 ALNY Rivian Automotive And Carvana Were Among The 10 Biggest Large Cap Gainers Last Week (June 23-June 29): Are These In Your Portfolio?
Jun 30 ANVS Annovis: Strong Sell Reiteration Prior To Phase 3 Data In Parkinson's Disease
Jun 30 LLY 5 Reasons Eli Lilly Just Keeps Rising
Jun 30 LLY 2 Top Healthcare Stocks to Buy in June
Jun 30 LLY 3 Reasons Why Altimmune Stock Could Be the Next Viking Therapeutics
Jun 29 LLY The Top Country With Most Scientists per Capita in the World
Jun 29 ALNY Selling US$7.7m Of Alnylam Pharmaceuticals Stock Rewarded Insiders
Jun 29 LLY This Is Massive News for Eli Lilly Investors
Jun 29 LLY Eli Lilly Is Teaming Up With OpenAI. Here Are 3 Things Smart Investors Should Know.
Amyloid

Amyloids are aggregates of proteins characterised by a fibrillar morphology of 7–13 nm in diameter, a β-sheet secondary structure (known as cross-β) and ability to be stained by particular dyes, such as Congo red. In the human body, amyloids have been linked to the development of various diseases. Pathogenic amyloids form when previously healthy proteins lose their normal structure and physiological functions (misfolding) and form fibrous deposits in plaques around cells which can disrupt the healthy function of tissues and organs.
Such amyloids have been associated with (but not necessarily as the cause of) more than 50 human diseases, known as amyloidosis, and may play a role in some neurodegenerative disorders. Some of these diseases are mainly sporadic and only a few cases are familial. Others are only familial. Some are iatrogenic as they result from medical treatment. One amyloid protein is infectious and is called prion in which the infectious form can act as a template to convert other non-infectious proteins into infectious form. Amyloids may also have normal biological functions; for example, in the formation of fimbriae in some genera of bacteria, transmission of epigenetic traits in fungi, as well as pigment deposition and hormone release in humans.Amyloids have been known to arise from many different proteins. These polypeptide chains generally form β-sheet structures that aggregate into long fibers; however, identical polypeptides can fold into multiple distinct amyloid conformations. The diversity of the conformations may have led to different forms of the prion diseases.

Browse All Tags